Improving Outcomes in NTM-LD: Strategies for Diagnosis, Individualized Treatment Plans and Patient Adherence
Guest: Charles Daley, MD
Guest: Shannon H. Kasperbauer, MD
Nontuberculous mycobacterial (NTM) lung disease is a chronic, progressive illness fraught with long treatments and severe side effects. The majority of NTM patients who have completed treatment can get it again. Research is emerging that may impact best practices in managing and treating patients with NTM along with new American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) guidelines. In this program, learn practical tools to diagnose, treat, and manage NTM.